|
|
||||||||
LIVER AND BILIARY TRACT
and HNF-1
revealed by mutations that cause maturity onset diabetes of the young
2Division of Biology and Biomedical Sciences, and 1Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri
Submitted 13 September 2005 ; accepted in final form 6 October 2005
Hepatic nuclear factor (HNF)-4
and HNF-1
are key endodermal transcriptional regulators that physically and functionally interact. HNF-4
and HNF-1
cooperatively activate genes with binding sites for both factors, whereas suppressive interactions occur at regulatory sequences with a binding site for only one factor. The liver fatty acid binding protein gene (Fabp1) has binding sites for both factors, and chromatin precipitation assays were utilized to demonstrate that HNF-4
increased HNF-1
Fabp1 promoter occupancy during cooperative transcriptional activation. The HNF4 P2 promoter contains a HNF-1 but not HNF-4 binding site, and HNF-4
suppressed HNF-1
HNF4 P2 activation and decreased promoter HNF-1
occupancy. The apolipoprotein C III (APOC3) promoter contains a HNF-4 but not HNF-1 binding site, and HNF-1
suppressed HNF-4
APOC3 activation and decreased HNF-4
promoter occupancy. Maturity onset diabetes of the young (MODY) as well as defects in hepatic lipid metabolism result from mutations in either HNF-4
or HNF-1
. We found that MODY missense mutant R127W HNF-4
retained wild-type individual Fabp1 activation and bound to HNF-1
better than wild-type HNF-4
, yet did not cooperate with HNF-1
or increase HNF-1
Fabp1 promoter occupancy. The R127W mutant was also defective in both suppressing HNF-1
activation of HNF4 P2 and decreasing HNF-1
promoter occupancy. The HNF-1
R131Q MODY mutant also retained wild-type Fabp1 activation and bound to HNF-4
as well as the wild type but was defective in both suppressing HNF-4
APOC3 activation and decreasing HNF-4
promoter occupancy. These results suggest HNF-1
-HNF-4
functional interactions are accomplished by regulating factor promoter occupancy and that defective factor-factor interactions may contribute to the MODY phenotype.
transcription factor; hepatic nuclear factor-4; hepatic nuclear factor-1
This article has been cited by other articles:
![]() |
A. Perilhou, C. Tourrel-Cuzin, P. Zhang, I. Kharroubi, H. Wang, V. Fauveau, D. K. Scott, C. B. Wollheim, and M. Vasseur-Cognet The MODY1 Gene for Hepatocyte Nuclear Factor 4{alpha} and a Feedback Loop Control COUP-TFII Expression in Pancreatic Beta Cells Mol. Cell. Biol., July 15, 2008; 28(14): 4588 - 4597. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Dietrich, I. V. Martin, A. C. Porn, S. Voigt, C. Gartung, C. Trautwein, and A. Geier Fasting induces basolateral uptake transporters of the SLC family in the liver via HNF4{alpha} and PGC1{alpha} Am J Physiol Gastrointest Liver Physiol, September 1, 2007; 293(3): G585 - G590. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Leng, S. Lu, Y. Yao, Z. Kan, G. S. Morris, B. R. Stair, M. A. Cherny, and D. D. Black Hepatocyte nuclear factor-4 mediates apolipoprotein A-IV transcriptional regulation by fatty acid in newborn swine enterocytes Am J Physiol Gastrointest Liver Physiol, August 1, 2007; 293(2): G475 - G483. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |